Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial

Current and future efforts toward the prevention of type 1 diabetes

(2016) Laura Jacobsen et al.   PEDIATRIC DIABETES

The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study

(2015) Jeffrey P. Krischer et al.   DIABETOLOGIA

Effects of High-Dose Oral Insulin on Immune Responses in Children at High Risk for Type 1 Diabetes

(2015) Ezio Bonifacio et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Baseline heterogeneity in glucose metabolism marks the risk for type 1 diabetes and complicates secondary prevention

(2014) Helena Elding Larsson et al.   ACTA DIABETOLOGICA

GAD Autoantibody Affinity in Adult Patients With Latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial

(2014) Stephanie Krause et al.   DIABETES CARE

Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetes

(2013) M. Pihl et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial

(2013) S. Axelsson et al.   DIABETES CARE

Diagnosis and Classification of Diabetes Mellitus

(2013)   DIABETES CARE

Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children

(2013) Anette G. Ziegler et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study

(2013) Cecilia Andersson et al.   PEDIATRIC DIABETES

GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus

(2012) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes

(2011) C. Andersson et al.   AUTOIMMUNITY

Reduced Prevalence of Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Young Children Participating in Longitudinal Follow-Up

(2011) H. Elding Larsson et al.   DIABETES CARE

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

(2011) Diane K Wherrett et al.   LANCET

GAD-alum treatment induces GAD65-specific CD4+CD25highFOXP3+ cells in type 1 diabetic patients

(2010) Maria Hjorth et al.   CLINICAL IMMUNOLOGY

GAD65 vaccination: 5 years of follow-up in a randomised dose-escalating study in adult-onset autoimmune diabetes

(2009) C.-D. Agardh et al.   DIABETOLOGIA

Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial

(2008) Kirsti Näntö-Salonen et al.   LANCET

GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes

(2008) Johnny Ludvigsson et al.   NEW ENGLAND JOURNAL OF MEDICINE